Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints During Oval Office Press Conference

A press conference at the White House on Thursday was interrupted when a man fainted in the Oval Office. President Donald Trump was announcing a deal with drugmakers to lower the cost of obesity medications.

Video and Reactions Online

The incident was captured on video and widely shared. Independent journalist Eric Daugherty posted the footage, saying:

"A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him. Pray for him."

Many viewers expressed their concern and offered prayers for the man's recovery as the live feed was cut short.

Initial Identification and Company Response

The man was initially thought to be Gordon Findlay, a Novo Nordisk executive, with some social media posts claiming:

"BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended."

However, Novo Nordisk clarified the situation, stating:

"CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay."

White House Clarification

White House Press Secretary Karoline Leavitt explained the event during the announcement:

"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted."
Summary

The fainting incident happened unexpectedly during a high-profile announcement, causing concern and prompting clarifications from both Novo Nordisk and the White House.

Author's summary: A man fainted during President Trump's Oval Office announcement on drug pricing; initial misidentification was corrected by Novo Nordisk and White House officials.

more

Hindustan Times Hindustan Times — 2025-11-06